Long-Term Study of CN-801 - Open-label study in patients with excessive daytime sleepiness associated with idiopathic hypersomnia -

Trial Profile

Long-Term Study of CN-801 - Open-label study in patients with excessive daytime sleepiness associated with idiopathic hypersomnia -

Completed
Phase of Trial: Phase III

Latest Information Update: 04 Feb 2017

At a glance

  • Drugs Modafinil (Primary)
  • Indications Hypersomnia
  • Focus Adverse reactions; Therapeutic Use
  • Sponsors Alfresa Pharma Corporation
  • Most Recent Events

    • 02 Feb 2017 Status changed from active, no longer recruiting to completed.
    • 10 Jun 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top